Amy Krambeck, MD presented “Overview of Current Surgical BPH” during the 2023 Frontiers in Oncologic Prostate Care and Ablative Local Therapy symposium on November 10, 2023, in Chicago, Illinois.
How to cite: Krambeck, Amy. “Overview of Current Surgical BPH” November, 2023. Accessed Dec 2024. https://grandroundsinurology.com/overview-of-current-surgical-bph/
Overview of Current Surgical BPH – Summary
Amy Krambeck, MD, provides a comprehensive overview of current surgical options for treating benign prostatic hyperplasia (BPH), focusing on their efficacy, safety, and practical application. Her analysis emphasizes the evolution of surgical techniques and the criteria for selecting the most appropriate intervention for each patient.
Dr. Krambeck begins by discussing transurethral resection of the prostate (TURP), noting its potential complications, such as bleeding, infection, and the risk of TUR syndrome, which necessitates careful patient selection and postoperative monitoring. She then explores newer surgical techniques as alternatives to TURP, among these, laser therapies such as holmium laser enucleation of the prostate (HoLEP) and photoselective vaporization of the prostate (PVP). Dr. Krambeck also addresses minimally invasive surgical options like prostatic urethral lift (PUL) and water vapor thermal therapy.
The discussion includes a review of the practical considerations for each surgical option, including patient factors such as prostate size, comorbidities, and symptom severity. Complications and postoperative care are also discussed.
Frontiers in Oncologic Prostate Care and Ablative Local Therapy (FOCAL) is an outstanding program on prostate imaging, transperineal interventions, and ablative treatments for prostate cancer and benign prostatic hyperplasia. Bringing together community-based, academic, and industry partners, FOCAL offers lectures by world-renowned faculty and hands-on training workshops on in-office transperineal interventions, fusion-guided prostate ablation and state-of-the-art BPH management with novel technologies.
ABOUT THE AUTHOR
Amy E. Krambeck, MD, is a professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois. Dr. Krambeck earned her medical degree from the University of Missouri School of Medicine in Columbia. She completed her urology residency at the Mayo Clinic in Rochester, Minnesota, where she received extensive training and refined her surgical expertise. Following her residency, Dr. Krambeck pursued an endourology fellowship at the Methodist Institute for Kidney Stone Research in Indianapolis, Indiana.
Dr. Krameck specializes in the surgical and medical management of stone disease and benign prostatic hyperplasia (BPH), and she has alleviated the symptoms of many patients. Her research focuses on the pathogenesis of stone disease and novel treatments for urolithiasis during pregnancy.
Dr. Krambeck began her career as an endourologist at the Mayo Clinic's Department of Urology, where she demonstrated exceptional surgical skills and a strong commitment to patient care. In 2016, Dr. Krambeck joined Indiana University, where she led the benign urologic diseases division until 2020. Her leadership and expertise significantly advanced the division, offering patients innovative treatments for various urologic conditions.
Dr. Krambeck's dedication to her patients, extensive knowledge, and research contributions have established her as a leading figure in urology. She continues to influence the future of urologic care through her clinical excellence and academic endeavors.
